Menu

Sana suspends work on allogeneic CAR-T; Biokin eyes $387M raise in Hong Kong

Article |

AmberPOR92 7mo ago
Sana suspends work on allogeneic CAR-T; Biokin eyes $387M raise in Hong Kong

Plus, news about Codexis, Gilead, nChroma Bio, Bavarian Nordic, UroGen, Agenus, Accipiter Biosciences and Immunocore: ✂️ Sana trims cell...

Comments (0)

Newest

No comments yet.